Das Sandeepan, Mallik Md Hasan, Chattopadyay Partha, Mallick Susenjit, Karmakar Dibyajyoti, Ghora Subhadip, Begum Feroza, Chatterjee Bilash, Thagriki Dluya Samuel, Srivastava Amit Kumar, Ray Upasana
CSIR-Indian Institute of Chemical Biology, Kolkata, West Bengal, India.
Academy of Scientific and Innovative Research, Ghaziabad, India.
J Virol. 2024 Dec 17;98(12):e0141824. doi: 10.1128/jvi.01418-24. Epub 2024 Nov 8.
Dengue virus NS1 protein is a major pathogenic protein. In this study, we examined the role of NS1 in coagulopathy associated with Dengue infection, a common feature of Dengue virus pathogenesis. Since most coagulation factors are produced by hepatocytes and liver is key organ affected during infection, we conducted transcriptomics using total-RNA extracted from Huh7 cells overexpressing NS1 protein. Coagulation factors 1, 5, 10, and 13 were downregulated and was confirmed using quantitative real-time polymerase chain reaction (RT-PCR) and western blot assays in both adherent and non-adherent cell culture systems across all four serotypes of Dengue. We also determined that downregulation of coagulation factors is a result of reduced expression of transcription activator HNF4α. Furthermore, we demonstrated that phosphorylation of extracellular signal-regulated kinase (ERK) leads to HNF4α downregulation and subsequent downregulation of coagulation factors. The downregulation of HNF4α and the downregulation of subsequent coagulation factors were validated in BALB/c mice by hydrodynamic tail vein injection of NS1 expression plasmids. Western blot assays using plasma from Dengue patients indicated that at least two coagulation factors of the common pathway of coagulation cascade are downregulated during the febrile phase, with levels improving toward the convalescent phase. NS1-mediated downregulation of coagulation factors was observed for both intracellular and secreted NS1. The hypothesis was also validated using virus infection assays. Overall, our study highlights the role of NS1 in mediating coagulopathy by modulating the expression of coagulation factors through transcriptional suppression of HNF4α by elevated phosphorylated ERK. This signaling cascade could be targeted for therapeutic intervention against virus-related coagulopathies.
Thrombocytopenia has been linked to coagulopathy of Dengue infection, and Dengue patients with coagulopathies are often administered platelet transfusion. For coagulopathies without thrombocytopenia, platelet transfusion might not help. We demonstrated the role of NS1 in coagulopathy by downregulating coagulation factors themselves. When thrombocytopenia does not exist or when thrombocytopenia as well as reduced levels of coagulation factors are the causative factors for coagulopathies, only platelet transfusion might not be effective. Alternative strategies, like administration of coagulation factor cocktails or platelet transfusion along with coagulation factor cocktail, might be promising. Our work also leads to a signaling pathway of NS1-mediated downregulation of coagulation factors via phosphorylated ERK and HNF4α. HNF4α is a transcription regulator for many other liver-based metabolic factors and pathways like lipid metabolism, carbohydrate metabolism, etc, and thus, therapeutic targeting of NS1-based downregulation of HNF4α can lead to designing therapeutic candidates for managing other Dengue-based liver dysfunction.
登革病毒NS1蛋白是一种主要的致病蛋白。在本研究中,我们研究了NS1在登革热感染相关凝血病中的作用,登革热感染相关凝血病是登革病毒发病机制的一个常见特征。由于大多数凝血因子由肝细胞产生,且肝脏是感染期间受影响的关键器官,我们使用从过表达NS1蛋白的Huh7细胞中提取的总RNA进行了转录组学研究。凝血因子1、5、10和13被下调,并在登革热所有四种血清型的贴壁和非贴壁细胞培养系统中通过定量实时聚合酶链反应(RT-PCR)和蛋白质印迹分析得到证实。我们还确定凝血因子的下调是转录激活因子HNF4α表达降低的结果。此外,我们证明细胞外信号调节激酶(ERK)的磷酸化导致HNF4α下调以及随后凝血因子的下调。通过水动力尾静脉注射NS1表达质粒在BALB/c小鼠中验证了HNF4α的下调和随后凝血因子的下调。使用登革热患者血浆进行的蛋白质印迹分析表明,在发热期,凝血级联共同途径的至少两种凝血因子被下调,且水平在恢复期有所改善。对于细胞内和分泌型NS1均观察到NS1介导的凝血因子下调。该假设也通过病毒感染试验得到验证。总体而言,我们的研究强调了NS1通过升高的磷酸化ERK对HNF4α的转录抑制来调节凝血因子表达,从而在介导凝血病中的作用。这种信号级联可能成为针对病毒相关凝血病的治疗干预靶点。
血小板减少症与登革热感染的凝血病有关,患有凝血病的登革热患者常接受血小板输注。对于无血小板减少症的凝血病,血小板输注可能无济于事。我们通过下调凝血因子本身证明了NS1在凝血病中的作用。当不存在血小板减少症或当血小板减少症以及凝血因子水平降低是凝血病的致病因素时,仅血小板输注可能无效。替代策略,如给予凝血因子鸡尾酒或血小板输注与凝血因子鸡尾酒联合使用,可能是有前景的。我们的工作还导致了一条NS1通过磷酸化ERK和HNF4α介导凝血因子下调的信号通路。HNF4α是许多其他基于肝脏的代谢因子和途径(如脂质代谢、碳水化合物代谢等)的转录调节因子,因此,基于NS1下调HNF4α的治疗靶点可用于设计治疗其他登革热相关肝功能障碍的候选药物。